Comment le bénéfice par action récent de HMGN se compare-t-il aux attentes ?
Comment les revenus de Hemagen Diagnostics Inc HMGN se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour Hemagen Diagnostics Inc ?
Quel est le score de qualité des bénéfices pour Hemagen Diagnostics Inc ?
Quand Hemagen Diagnostics Inc publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de Hemagen Diagnostics Inc ?
Hemagen Diagnostics Inc a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$0.0002
Prix d'ouverture
$0.0001
Plage de la journée
$0.0001 - $0.0002
Plage de 52 semaines
$0.0001 - $0.0201
Volume
9.3K
Volume moyen
506
BPA (TTM)
-0.06
Rendement en dividend
--
Capitalisation boursière
$3.1K
Qu’est-ce que HMGN ?
Hemagen Diagnostics, Inc. is a biotechnology company. The company is headquartered in Columbia, Maryland and currently employs 15 full-time employees. The firm is primarily focused on Veterinary Clinical Diagnostics. The company is also focused on VIRGO, its Human Clinical Diagnostic line of autoimmune and infectious disease products. The firm develops, manufactures and markets a range of test kits used to aid in the diagnosis of certain autoimmune and infectious diseases. The Company’s autoimmune product portfolio includes Hemagen DNA Kit, Hemagen Rheumatoid Factor Kit, VIRGO AMA IgG, VIRGO ANA/Hep-2 IgG, VIRGO Anti-nDNA IgG, VIRGO cANCA (PR-3) Kit, VIRGO dsDNA Kit, VIRGO ENA Screen 6 Kit, VIRGO ENA Screening, VIRGO ENA Series, VIRGO pANCA myeloperoxidase (MPO) Kit and VIRGO Rheumatoid Factor Kit. The company offers various products for infectious disease, which includes VIRGO C. trach IgG, VIRGO CMV IgG and VIRGO epstein-barr virus (EBV)- viral capsid antigen (VCA) IgG. Its products are used in laboratories, hospitals and blood banks around the world.